{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:15:45Z","timestamp":1793643345092,"version":"4.5.1"},"reference-count":111,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mould pneumonia can be life-threatening, and its incidence is increasing in Asia. Due to significant variability in diagnostic setups and the availability of antifungal agents, especially in resource-limited settings, the current treatment practices and recommendations for local clinicians are poorly described. This study aimed to develop a consensus statement on the clinical management of mould pneumonia in Asia, particularly within resource-limited settings. Clinicians and infectious disease experts from the Asia Fungal Working Group answered questions about the regional epidemiology as well as diagnostic and resource-limited treatment approaches of mould pneumonia. Guided by a literature review, 22 initial questions were generated and voted upon anonymously using a Delphi-based methodology with predefined consensus criteria. The study comprised two rounds: one to generate summary statements based on the panelists\u2019 questionnaire responses, and the other to review, confirm and rate the level of agreement of the consensus statements using a five-point Likert scale. The panelists generated 21 summary statements on the epidemiology (5), diagnosis (8), and treatment (8) of mould pneumonia, 20 of which achieved\u00a0\u2265\u00a070% consensus. Through a consensus-building exercise, clinical experts from Asia developed a set of 21 consensus statements for the diagnosis and management of mould pneumonia in resource-limited settings.<\/jats:p>","DOI":"10.1093\/mmy\/myaf106","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T12:33:14Z","timestamp":1763382794000},"source":"Crossref","is-referenced-by-count":1,"title":["Management of mould pneumonia in resource-limited settings in Asia: A Delphi-based consensus statement by the Asia Fungal Working Group"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4582-4914","authenticated-orcid":false,"given":"Methee","family":"Chayakulkeeree","sequence":"first","affiliation":[{"name":"Mahidol University Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, , Bangkok 10400 ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1458-9456","authenticated-orcid":false,"given":"Ban Hock","family":"Tan","sequence":"additional","affiliation":[{"name":"Singapore General Hospital Department of Infectious Diseases, , 169608 ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1816-9010","authenticated-orcid":false,"given":"Yee-Chun","family":"Chen","sequence":"additional","affiliation":[{"name":"National Taiwan University Hospital and College of Medicine Department of Internal Medicine, , Taipei City 100 ,","place":["Taiwan"]},{"name":"National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes , Zhunan, Miaoli County 35053 ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2859-0025","authenticated-orcid":false,"given":"Atul","family":"Patel","sequence":"additional","affiliation":[{"name":"Infectious Diseases Clinic, Vedanta Institute of Medical Sciences , Navarangpura, Ahmedabad 380009 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2302-3577","authenticated-orcid":false,"given":"Ruoyu","family":"Li","sequence":"additional","affiliation":[{"name":"Peking University First Hospital, National Clinical Research Centre for Skin and Immune Diseases, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics Department of Dermatology and Venereology, , Beijing 100034 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-1670","authenticated-orcid":false,"given":"Ariya","family":"Chindamporn","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Chulalongkorn University Department of Microbiology, , Bangkok 10330 ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2645-2462","authenticated-orcid":false,"given":"Mitzi","family":"Chua","sequence":"additional","affiliation":[{"name":"Cebu Institute of Medicine Department of Microbiology and Parasitology, , Cebu City 6000 ,","place":["Philippines"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2497-7847","authenticated-orcid":false,"given":"Kauser","family":"Jabeen","sequence":"additional","affiliation":[{"name":"Aga Khan University Department of Pathology & Laboratory Medicine, , Karachi 74800 ,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Phu Huong","family":"Lan","sequence":"additional","affiliation":[{"name":"Hospital for Tropical Diseases , Ho Chi Minh City 700000 ,","place":["Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7446-9434","authenticated-orcid":false,"given":"Lee Lee","family":"Low","sequence":"additional","affiliation":[{"name":"Hospital Sultanah Bahiyah Department of Medicine, , Alor Setar 05460, Kedah ,","place":["Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9868-4628","authenticated-orcid":false,"given":"Pei-Lun","family":"Sun","sequence":"additional","affiliation":[{"name":"Chang Gung Memorial Hospital Department of Dermatology, , Linkou Branch, Taoyuan 33302 ,","place":["Taiwan"]},{"name":"College of Medicine, Chang Gung University , Taoyuan 33302 ,","place":["Taiwan"]},{"name":"Research Laboratory of Medical Mycology, Chang Gung Memorial Hospital , Linkou Branch, Taoyuan 33302 ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1888-0806","authenticated-orcid":false,"given":"Retno","family":"Wahyuningsih","sequence":"additional","affiliation":[{"name":"Universitas Indonesia Department of Parasitology, Faculty of Medicine, , Jakarta 10430 ,","place":["Indonesia"]},{"name":"Universitas Kristen Indonesia Department of Parasitology, Faculty of Medicine, , Jakarta 10430 ,","place":["Indonesia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3098-7307","authenticated-orcid":false,"given":"Li-Ping","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University Department of Infectious Diseases, , Shanghai 200051 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1555-3807","authenticated-orcid":false,"given":"Arunaloke","family":"Chakrabarti","sequence":"additional","affiliation":[{"name":"Doodhadhari Burfani Hospital and Research Institute , Haridwar, Uttarakhand 249410 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"6","key":"2025120105070212100_bib1","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis."},{"issue":"4","key":"2025120105070212100_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases\u2014Estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi"},{"issue":"4","key":"2025120105070212100_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025120105070212100_bib4","doi-asserted-by":"crossref","first-page":"1256158","DOI":"10.3389\/fcimb.2024.1256158","article-title":"Diagnosis and management of invasive fungal diseases in non-neutropenic ICU patients, with focus on candidiasis and aspergillosis: A comprehensive review","volume":"14","author":"Azim","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"2025120105070212100_bib5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2147\/CEOR.S308744","article-title":"Patient characteristics and risk factors in invasive mold infections: Comparison from a systematic review and database analysis","volume":"13","author":"Sung","year":"2021","journal-title":"ClinicoEcon Outcomes Res"},{"issue":"1","key":"2025120105070212100_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3947\/ic.2022.0151","article-title":"Diagnosis and treatment of invasive mold diseases","volume":"55","author":"Lee","year":"2023","journal-title":"Infect Chemother"},{"issue":"1","key":"2025120105070212100_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12929-023-00926-2","article-title":"Diagnosis of invasive fungal infections: Challenges and recent developments","volume":"30","author":"Fang","year":"2023","journal-title":"J Biomed Sci"},{"issue":"7","key":"2025120105070212100_bib8","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025120105070212100_bib9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ijid.2020.01.007","article-title":"Clinicians\u2019 challenges in managing patients with invasive fungal diseases in seven Asian countries: An Asia Fungal Working Group (AFWG) Survey","volume":"95","author":"Tan","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"3","key":"2025120105070212100_bib10","doi-asserted-by":"crossref","first-page":"106718","DOI":"10.1016\/j.ijantimicag.2023.106718","article-title":"The current state of laboratory mycology in Asia\/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)","volume":"61","author":"Salmanton-Garc\u00eda","year":"2023","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"2025120105070212100_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/13693786.2011.602989","article-title":"Opportunistic fungal infections in the Asia-Pacific region","volume":"50","author":"Slavin","year":"2012","journal-title":"Med Mycol"},{"issue":"1","key":"2025120105070212100_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash","year":"2019","journal-title":"J Fungi"},{"key":"2025120105070212100_bib13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infec"},{"issue":"S7","key":"2025120105070212100_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/imj.15592","article-title":"Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology\/oncology setting, 2021","volume":"51","author":"Bupha-Intr","year":"2021","journal-title":"Intern Med J"},{"issue":"S7","key":"2025120105070212100_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/imj.15591","article-title":"Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021","volume":"51","author":"Douglas","year":"2021","journal-title":"Intern Med J"},{"issue":"3","key":"2025120105070212100_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/jof9030357","article-title":"Dual disseminated aspergillosis and mucormycosis diagnosed at autopsy: A report of two cases of coinfection and a review of the literature","volume":"9","author":"Murray","year":"2023","journal-title":"J Fungi"},{"issue":"8","key":"2025120105070212100_bib17","doi-asserted-by":"crossref","first-page":"myae081","DOI":"10.1093\/mmy\/myae081","article-title":"Aspergillosis coinfection in patients with proven mucormycosis","volume":"62","author":"Ra","year":"2024","journal-title":"Med Mycol"},{"issue":"1","key":"2025120105070212100_bib18","doi-asserted-by":"crossref","first-page":"e1004326","DOI":"10.1371\/journal.pmed.1004326","article-title":"ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi","volume":"21","author":"Gattrell","year":"2024","journal-title":"PLoS Med"},{"issue":"5","key":"2025120105070212100_bib19","doi-asserted-by":"crossref","first-page":"e1004390","DOI":"10.1371\/journal.pmed.1004390","article-title":"ACcurate COnsensus Reporting Document (ACCORD) explanation and elaboration: Guidance and examples to support reporting consensus methods","volume":"21","author":"Logullo","year":"2024","journal-title":"PLoS Med"},{"issue":"4","key":"2025120105070212100_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/10903127.2013.818176","article-title":"Recommendations on ambulance cardiopulmonary resuscitation in basic life support systems","volume":"17","author":"Hock\u00a0Ong","year":"2013","journal-title":"Prehosp Emerg Care"},{"issue":"2","key":"2025120105070212100_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/mmy\/myx029","article-title":"Epidemiology and clinical characteristics of invasive mould infections: A multicenter, retrospective analysis in five Asian countries","volume":"56","author":"Rotjanapan","year":"2018","journal-title":"Med Mycol"},{"key":"2025120105070212100_bib22","first-page":"20499361241252537","article-title":"Distribution of Aspergillus species and risk factors for aspergillosis in mainland china: A systematic review","volume":"11","author":"Khan","year":"2024","journal-title":"Ther Adv Infect Dis"},{"issue":"1","key":"2025120105070212100_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin Microbiol Infec"},{"issue":"11","key":"2025120105070212100_bib24","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/myc.13484","article-title":"Disease burden and demographic characteristics of mucormycosis: A nationwide population-based study in Taiwan, 2006\u20132017","volume":"65","author":"Shih","year":"2022","journal-title":"Mycoses"},{"key":"2025120105070212100_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcrc.2019.02.005","article-title":"Epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study)","volume":"51","author":"Chakrabarti","year":"2019","journal-title":"J Crit Care"},{"issue":"3","key":"2025120105070212100_bib26","doi-asserted-by":"crossref","first-page":"101393","DOI":"10.1016\/j.mycmed.2023.101393","article-title":"COVID-19-associated mucormycosis in India: Why such an outbreak?","volume":"33","author":"Pasquier","year":"2023","journal-title":"J Med Mycol"},{"issue":"1","key":"2025120105070212100_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11046-021-00607-4","article-title":"Mucormycosis in mainland China: A systematic review of case reports","volume":"187","author":"Wei","year":"2022","journal-title":"Mycopathologia"},{"issue":"4","key":"2025120105070212100_bib28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/mmy\/myy060","article-title":"A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment","volume":"57","author":"Prakash","year":"2019","journal-title":"Med Mycol"},{"issue":"4","key":"2025120105070212100_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s15010-018-1149-x","article-title":"Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome","volume":"46","author":"Feng","year":"2018","journal-title":"Infection"},{"issue":"4","key":"2025120105070212100_bib30","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0003-4975(94)90243-7","article-title":"Pulmonary mucormycosis: Results of medical and surgical therapy","volume":"57","author":"Tedder","year":"1994","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"2025120105070212100_bib31","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.159.12.1301","article-title":"Pulmonary mucormycosis: The last 30 years","volume":"159","author":"Lee","year":"1999","journal-title":"Arch Inter Med"},{"issue":"1","key":"2025120105070212100_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes\u2014Global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2019","journal-title":"J Epidemiol Global Health"},{"issue":"3","key":"2025120105070212100_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jinf.2016.06.013","article-title":"The burden of mucormycosis in HIV-infected patients: A systematic review","volume":"73","author":"Moreira","year":"2016","journal-title":"J Infect"},{"issue":"2","key":"2025120105070212100_bib34","doi-asserted-by":"crossref","first-page":"e13774","DOI":"10.1111\/ctr.13774","article-title":"Mucormycosis in lung transplant recipients: A systematic review of the literature and a case series","volume":"34","author":"Wand","year":"2020","journal-title":"Clin Transplant"},{"issue":"5","key":"2025120105070212100_bib35","first-page":"343","article-title":"Procalcitonin\u2014A marker of invasive fungal infection?","volume":"13","author":"Dornbusch","year":"2005","journal-title":"Support Care Cancer"},{"issue":"1","key":"2025120105070212100_bib36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13054-018-2050-9","article-title":"Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia","volume":"22","author":"Thomas-R\u00fcddel","year":"2018","journal-title":"Crit Care"},{"issue":"4","key":"2025120105070212100_bib37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/QCO.0000000000000937","article-title":"Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: Are we making progress?","volume":"36","author":"Lewis","year":"2023","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"2025120105070212100_bib38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmi.2023.08.013","article-title":"Lung and sinus fungal infection imaging in immunocompromised patients","volume":"30","author":"Lamoth","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2025120105070212100_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","article-title":"An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients","volume":"183","author":"Limper","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2025120105070212100_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cid\/ciae203","article-title":"Breakthrough invasive fungal infections in patients with high-risk hematological disorders receiving voriconazole and posaconazole prophylaxis: A systematic review","volume":"79","author":"Boutin","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2025120105070212100_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jiph.2012.01.003","article-title":"Cerebro-rhino orbital mucormycosis: An update","volume":"5","author":"Wali","year":"2012","journal-title":"J Infect Public Health"},{"issue":"5","key":"2025120105070212100_bib42","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.chest.2019.06.032","article-title":"Advances in the diagnosis and management of invasive fungal disease","volume":"156","author":"Formanek","year":"2019","journal-title":"Chest"},{"issue":"3","key":"2025120105070212100_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12281-018-0321-1","article-title":"Role of serological tests in the diagnosis of mold infections","volume":"12","author":"Richardson","year":"2018","journal-title":"Curr Fung Infect Rep"},{"issue":"6","key":"2025120105070212100_bib44","doi-asserted-by":"crossref","first-page":"ofac112","DOI":"10.1093\/ofid\/ofac112","article-title":"Noninvasive testing and surrogate markers in invasive fungal diseases","volume":"9","author":"Thompson","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"2025120105070212100_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13054-019-2348-2","article-title":"Invasive and non-invasive diagnostic approaches for microbiological diagnosis of hospital-acquired pneumonia","volume":"23","author":"Ranzani","year":"2019","journal-title":"Crit Care"},{"issue":"3","key":"2025120105070212100_bib46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/1817-1737.114302","article-title":"Association of bronchoalveolar lavage yield with chest computed tomography findings and symptoms in immunocompromised patients","volume":"8","author":"Brownback","year":"2013","journal-title":"Ann Thorac Med"},{"issue":"9","key":"2025120105070212100_bib47","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/cid\/cir122","article-title":"The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts","volume":"52","author":"Georgiadou","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2025120105070212100_bib48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/509917","article-title":"Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign","volume":"44","author":"Greene","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2025120105070212100_bib49","first-page":"TE01","article-title":"Pulmonary aspergillosis: What CT can offer before it is too late!","volume":"10","author":"Prasad","year":"2016","journal-title":"J Clin Diagn Res."},{"issue":"8","key":"2025120105070212100_bib50","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: An expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"},{"issue":"9","key":"2025120105070212100_bib51","first-page":"1","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Airways Group, ed","volume":"2017","author":"Leeflang","year":"2015","journal-title":"Cochrane Db Syst Rev."},{"issue":"12","key":"2025120105070212100_bib52","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/jcpt.13792","article-title":"Diagnostic value of bronchoalveolar lavage fluid galactomannan assay for invasive pulmonary aspergillosis in adults: A meta-analysis","volume":"47","author":"Li","year":"2022","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"2025120105070212100_bib53","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/jof9060674","article-title":"The use of galactomannan antigen assays for the diagnosis of invasive pulmonary aspergillosis in the hematological patient: A systematic review and meta-analysis","volume":"9","author":"Bukkems","year":"2023","journal-title":"J Fungi"},{"issue":"10","key":"2025120105070212100_bib54","doi-asserted-by":"crossref","first-page":"ovad110","DOI":"10.1093\/lambio\/ovad110","article-title":"Diagnosis of invasive pulmonary aspergillosis by lateral flow assay of galactomannan in bronchoalveolar lavage fluid: A meta-analysis of diagnostic performance","volume":"76","author":"Cai","year":"2023","journal-title":"Lett Appl Microbiol"},{"issue":"5","key":"2025120105070212100_bib55","doi-asserted-by":"crossref","first-page":"e37067","DOI":"10.1097\/MD.0000000000037067","article-title":"Diagnostic performance of serum galactomannan and \u03b2-D-glucan for invasive aspergillosis in suspected patients: A meta-analysis","volume":"103","author":"Huang","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2025120105070212100_bib56","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/jof8040400","article-title":"Efficacy of LD bio Aspergillus ICT lateral flow assay for serodiagnosis of chronic pulmonary aspergillosis","volume":"8","author":"Ray","year":"2022","journal-title":"J Fungi"},{"issue":"2","key":"2025120105070212100_bib57","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10096-023-04724-4","article-title":"Performance of the Aspergillus galactomannan lateral flow assay with a digital reader for the diagnosis of invasive aspergillosis: A multicenter study","volume":"43","author":"Guo","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"15","key":"2025120105070212100_bib58","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.3390\/s21155185","article-title":"Ten years of lateral flow immunoassay technique applications: Trends, challenges and future perspectives","volume":"21","author":"Di\u00a0Nardo","year":"2021","journal-title":"Sensors"},{"issue":"14","key":"2025120105070212100_bib59","doi-asserted-by":"crossref","first-page":"e34569","DOI":"10.1016\/j.heliyon.2024.e34569","article-title":"Diagnostic accuracy of galactomannan and lateral flow assay in invasive aspergillosis: A diagnostic meta-analysis","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"issue":"8","key":"2025120105070212100_bib60","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/jac\/dkad143","article-title":"Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)","volume":"78","author":"Stemler","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"2025120105070212100_bib61","doi-asserted-by":"crossref","first-page":"e13544","DOI":"10.1111\/ctr.13544","article-title":"Invasive aspergillosis in solid-organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Husain","year":"2019","journal-title":"Clin Transplant"},{"issue":"3","key":"2025120105070212100_bib62","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/jac\/dkaa498","article-title":"The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis","volume":"76","author":"Cruciani","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2025120105070212100_bib63","article-title":"Review of laboratory diagnostic tests for invasive aspergillosis","author":"Deng","journal-title":"Med Lab Observer"},{"issue":"8","key":"2025120105070212100_bib64","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.cmi.2023.05.012","article-title":"How to use direct microscopy for diagnosing fungal infections","volume":"29","author":"Knoll","year":"2023","journal-title":"Clin Microbiol Infec"},{"issue":"4","key":"2025120105070212100_bib65","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12281-014-0204-z","article-title":"Interpretation of fungal culture results","volume":"8","author":"Borman","year":"2014","journal-title":"Curr Fung Infect Rep"},{"issue":"10273","key":"2025120105070212100_bib66","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","article-title":"Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: A phase 3, randomised, controlled, non-inferiority trial","volume":"397","author":"Maertens","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"2025120105070212100_bib67","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/jof4030098","article-title":"Treatment of aspergillosis","volume":"4","author":"Jenks","year":"2018","journal-title":"J Fungi"},{"issue":"suppl_1","key":"2025120105070212100_bib68","doi-asserted-by":"crossref","first-page":"i48","DOI":"10.1093\/jac\/dkx033","article-title":"New pharmacological opportunities for the treatment of invasive mould diseases","volume":"72","author":"Ledoux","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"2025120105070212100_bib69","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41429-021-00431-4","article-title":"Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and western Pacific region: Data from the SENTRY antifungal surveillance program (2011\u20132019)","volume":"74","author":"Pfaller","year":"2021","journal-title":"J Antibiot"},{"issue":"1","key":"2025120105070212100_bib70","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s12879-024-09477-9","article-title":"Compare the efficacy of antifungal agents as primary therapy for invasive aspergillosis: A network meta-analysis","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"2","key":"2025120105070212100_bib71","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: A randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med."},{"key":"2025120105070212100_bib72","doi-asserted-by":"crossref","first-page":"20420986221143266","DOI":"10.1177\/20420986221143266","article-title":"Safety of triazole antifungals: A pharmacovigilance study from 2004 to 2021 based on FAERS","volume":"13","author":"Chai","year":"2022","journal-title":"Ther Adv Drug Saf"},{"issue":"9","key":"2025120105070212100_bib73","doi-asserted-by":"crossref","first-page":"ofad424","DOI":"10.1093\/ofid\/ofad424","article-title":"Real-world use of mold-active triazole prophylaxis in the prevention of invasive fungal diseases: Results from a subgroup analysis of a multicenter national registry","volume":"10","author":"Nguyen","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"2025120105070212100_bib74","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5500\/wjt.v11.i9.356","article-title":"Voriconazole-associated periostitis: Pathophysiology, risk factors, clinical manifestations, diagnosis, and management","volume":"11","author":"Guarascio","year":"2021","journal-title":"World J Transplant"},{"issue":"2","key":"2025120105070212100_bib75","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaad.2018.08.010","article-title":"Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: A systematic review and meta-analysis","volume":"80","author":"Tang","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2025120105070212100_bib76","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s13224-021-01586-8","article-title":"Common antifungal drugs in pregnancy: Risks and precautions","volume":"71","author":"Patel","year":"2021","journal-title":"J Obstet Gynecol India"},{"issue":"6","key":"2025120105070212100_bib77","doi-asserted-by":"crossref","first-page":"193","DOI":"10.52403\/ijrr.20210623","article-title":"\u201cMucormycosis\u201d the emerging global threat\u2014A complete review","volume":"8","author":"Shabaraya","year":"2021","journal-title":"Int J Res Rev"},{"issue":"10","key":"2025120105070212100_bib78","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: A retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"1","key":"2025120105070212100_bib79","doi-asserted-by":"crossref","first-page":"061","DOI":"10.1055\/s-0043-1776776","article-title":"Antifungal therapies for Aspergillus spp.: Present and future","volume":"45","author":"Eschenauer","year":"2024","journal-title":"Sem Resp Crit Care Med"},{"issue":"9","key":"2025120105070212100_bib80","doi-asserted-by":"crossref","first-page":"e1552","DOI":"10.1016\/S2214-109X(24)00225-0","article-title":"Paving the way for affordable and equitable liposomal amphotericin B access worldwide","volume":"12","author":"Lee","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"10","key":"2025120105070212100_bib82","doi-asserted-by":"crossref","first-page":"e1010858","DOI":"10.1371\/journal.ppat.1010858","article-title":"Current treatments against mucormycosis and future directions. Chowdhary A, ed","volume":"18","author":"Smith","year":"2022","journal-title":"PLOS Pathog."},{"key":"2025120105070212100_bib83","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.12688\/f1000research.151564.1","article-title":"Management of pulmonary mucormycosis: A systematic review","volume":"13","author":"Fadelelmoula","year":"2024","journal-title":"F1000Res"},{"issue":"3","key":"2025120105070212100_bib84","doi-asserted-by":"crossref","first-page":"101007","DOI":"10.1016\/j.mycmed.2020.101007","article-title":"Mucormycosis treatment: Recommendations, latest advances, and perspectives","volume":"30","author":"Brunet","year":"2020","journal-title":"J Mycol M\u00e9d"},{"key":"2025120105070212100_bib85","doi-asserted-by":"crossref","first-page":"CD010481","DOI":"10.1002\/14651858.CD010481","article-title":"Amphotericin B deoxycholate versus liposomal amphotericin B: Effects on kidney function","volume-title":"Cochrane Database of Systematic Reviews","author":"Botero\u00a0Aguirre","year":"2013"},{"issue":"4","key":"2025120105070212100_bib86","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clinthera.2024.01.011","article-title":"Effectiveness, tolerability, and safety of different amphotericin B formulations in invasive fungal infections: A multicenter, retrospective, observational study","volume":"46","author":"Cavassin","year":"2024","journal-title":"Clin Ther"},{"issue":"7","key":"2025120105070212100_bib87","doi-asserted-by":"crossref","first-page":"944.e9","DOI":"10.1016\/j.cmi.2019.11.021","article-title":"A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India","volume":"26","author":"Patel","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"2025120105070212100_bib88","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/jphp.12802","article-title":"Efficacy and safety of amphotericin B formulations: A network meta-analysis and a multicriteria decision analysis","volume":"69","author":"Tonin","year":"2017","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"2025120105070212100_bib89","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/myc.12585","article-title":"Efficacy and safety of amphotericin B lipid-based formulations\u2014A systematic review and meta-analysis","volume":"60","author":"Steimbach","year":"2017","journal-title":"Mycoses"},{"issue":"01","key":"2025120105070212100_bib90","doi-asserted-by":"crossref","first-page":"28","DOI":"10.58999\/cijmr.v3i01.157","article-title":"Pulmonary mucormycosis: A case report and systematic review of the literature","volume":"3","author":"Agrawal","year":"2024","journal-title":"Cent India J Med Res"},{"issue":"3","key":"2025120105070212100_bib91","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/jof9030307","article-title":"What is new in pulmonary mucormycosis?","volume":"9","author":"Danion","year":"2023","journal-title":"J Fungi"},{"issue":"3","key":"2025120105070212100_bib92","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40506-021-00250-z","article-title":"Salvage therapy for the treatment of mucormycosis","volume":"13","author":"Patel","year":"2021","journal-title":"Curr Treat Options Infect Dis"},{"issue":"10","key":"2025120105070212100_bib93","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/myc.12801","article-title":"Cost-effectiveness of amphotericin B formulations in the treatment of systemic fungal infections","volume":"61","author":"Borba","year":"2018","journal-title":"Mycoses"},{"issue":"1","key":"2025120105070212100_bib94","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40258-013-0072-7","article-title":"Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States","volume":"12","author":"Yang","year":"2014","journal-title":"Appl Health Econ Health Policy"},{"issue":"4","key":"2025120105070212100_bib95","doi-asserted-by":"crossref","first-page":"e4159","DOI":"10.55251\/jmbfs.4159","article-title":"Triazole resistance in Aspergillus fumigatus\u2014A comprehensive review","volume":"11","author":"Wadhwa","year":"2022","journal-title":"J Microbiol Biotechnol Food Sci"},{"issue":"7","key":"2025120105070212100_bib96","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmi.2018.11.027","article-title":"Triazole resistance in Aspergillus fumigatus: Recent insights and challenges for patient management","volume":"25","author":"Lestrade","year":"2019","journal-title":"Clin Microbiol Infec"},{"issue":"suppl_3","key":"2025120105070212100_bib97","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jix210","article-title":"Azole-resistant aspergillosis: Epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Chowdhary","year":"2017","journal-title":"J Infect Dis"},{"key":"2025120105070212100_bib98","doi-asserted-by":"crossref","first-page":"957577","DOI":"10.3389\/ffunb.2022.957577","article-title":"Experimental and in-host evolution of triazole resistance in human pathogenic fungi","volume":"3","author":"Handelman","year":"2022","journal-title":"Front Fungal Biol"},{"key":"2025120105070212100_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2015.00428","article-title":"Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia","volume":"6","author":"Chowdhary","year":"2015","journal-title":"Front Microbiol"},{"issue":"3","key":"2025120105070212100_bib100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/jof2030021","article-title":"Triazole resistance in Aspergillus spp.: A worldwide problem?","volume":"2","author":"Rivero-Menendez","year":"2016","journal-title":"J Fungi"},{"issue":"suppl_1","key":"2025120105070212100_bib101","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1093\/mmy\/myx144","article-title":"Triazole resistance surveillance in Aspergillus fumigatus","volume":"56","author":"Resendiz\u00a0Sharpe","year":"2018","journal-title":"Med Mycol"},{"issue":"15","key":"2025120105070212100_bib102","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1517\/14656566.2015.1083976","article-title":"Treatment of drug-resistant Aspergillus infection","volume":"16","author":"Aigner","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"2025120105070212100_bib103","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.22207\/JPAM.16.4.15","article-title":"Dual fungal infection of aspergillosis and mucormycosis in a COVID-19 patient: A rare case report","volume":"16","author":"Nikhil","year":"2022","journal-title":"J Pure Appl Microbiol"},{"issue":"1","key":"2025120105070212100_bib104","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12890-024-03234-z","article-title":"Successful treatment of mixed pulmonary Aspergillus and Mucor infection using intrabronchial amphotericin B infusion: A case report and literature review","volume":"24","author":"Ling","year":"2024","journal-title":"BMC Pulm Med"},{"issue":"Supplement_1","key":"2025120105070212100_bib105","doi-asserted-by":"crossref","first-page":"myac072P145","DOI":"10.1093\/mmy\/myac072.P145","article-title":"P145 co-infections due to Aspergillus and Mucorales: Case series from a superspecialty medical center in India","volume":"60","author":"Rana","year":"2022","journal-title":"Med Mycol"},{"key":"2025120105070212100_bib106","doi-asserted-by":"crossref","first-page":"1387278","DOI":"10.3389\/fmed.2024.1387278","article-title":"The first child with mixed invasive pulmonary mucor and aspergillus infection: A case report and literature review","volume":"11","author":"Wang","year":"2024","journal-title":"Front Med"},{"issue":"1","key":"2025120105070212100_bib107","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s43163-023-00451-x","article-title":"Management of mucormycosis coexisting with aspergillosis in pediatric age group\u2014A case report","volume":"39","author":"Gopal","year":"2023","journal-title":"Egypt J Otolaryngol"},{"issue":"8","key":"2025120105070212100_bib108","doi-asserted-by":"crossref","first-page":"e255909","DOI":"10.1136\/bcr-2023-255909","article-title":"Isolated cerebral mucormycosis and aspergillosis coinfection in an immunocompromised adult","volume":"16","author":"Sun","year":"2023","journal-title":"BMJ Case Rep"},{"issue":"2","key":"2025120105070212100_bib109","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/0049475519825561","article-title":"Managing mucormycosis in a resource-limited setting: Challenges and possible solutions","volume":"49","author":"Gupta","year":"2019","journal-title":"Trop Doct"},{"issue":"2","key":"2025120105070212100_bib110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/jopcs.jopcs_26_22","article-title":"Management of invasive mold infections: An Indian perspective review","volume":"4","author":"Prayag","year":"2023","journal-title":"J Prim Care Spec"},{"issue":"10","key":"2025120105070212100_bib111","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1093\/jac\/dkac251","article-title":"Unmet needs and practical solutions in the management of invasive mould infections in Asia","volume":"77","author":"Chen","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"2025120105070212100_bib112","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/14787210.2023.2257895","article-title":"Overcoming clinical challenges in the management of invasive fungal infections in low- and middle-income countries (LMIC)","volume":"21","author":"Chakrabarti","year":"2023","journal-title":"Expert Rev Anti-Infect Ther"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myaf106\/65370361\/myaf106.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/12\/myaf106\/65370361\/myaf106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/12\/myaf106\/65370361\/myaf106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T10:07:21Z","timestamp":1764583641000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myaf106\/8326528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":111,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myaf106","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,18]]},"article-number":"myaf106"}}